StockData
Parabilis Medicines, Inc. logo

Parabilis Medicines, Inc. (PBLS) stock

PBLSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$28.25−0.20 (-0.70%)

Close on Nov 17, 2026Market cap $3.49BP/E –Yield –

Parabilis Medicines operating margin

Operating margin is operating income as a percentage of revenue.

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-34382.4%–

More Parabilis Medicines figures

See a number that looks wrong?